Proteus Sustained Behavior Change Study

NCT01503008 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DEVICE: Proteus Sustained Behavior Change system
DRUG: Regularly prescribed diabetes medicines (metformin, sulfonylureas, thiazolidinediones, DPP-IV inhibitors, alpha-glucosidase inhibitors)

Sponsor

Proteus Digital Health, Inc.